房颤抗栓治疗临床分析 Clinical Analysis of Antithrombotic Treatment of Atrial Fibrillation.pdfVIP

230 Chinese Journal of Medicinal Guide 2012 Volume 14 No.2 (Serial No.100) 房颤抗栓治疗临床分析 1 2 韩忠芳 ,严国胜 1 2 ( 江苏省滨海县康达中西医结合医院心内科,滨海224500; 江苏省滨海县第二人民医院心内科,滨海224500) 【 】 分析房颤患者抗栓治疗和抗凝治疗的疗效和安全性。 回顾性分析我院住院的患者140例,分为阿司匹林组85例 摘要 目的: 方法: 和华法林组55例;观察两组的疗效和安全性。结果:阿司匹林组缺血性事件发生率明显高于华法林组(P ＜0.05);但华法林组出血性事 件发生率明显高于阿司匹林两组(P ＜0.05) 。结论:对于房颤患者,不仅应积极进行栓塞的危险分层管理,还需进行出血的危险分层, 权衡出血和栓塞的风险,把好抗栓治疗与预防出血的平衡,使患者最大程度受益于抗栓治疗。 【 】房颤;阿司匹林;华法林;抗栓治疗 关键词 【中图分类号】R54 1　 【文献标识码】A　 【文章编号】1009-0959(2010)02-0230-02 Clinical Analysis of Antithrombotic Treatment of Atrial Fibrillation Han Zhong-fang 1, yan Guo-sheng2 1 ( Binhai County, Jiangsu Province Hospital of Integrated Chinese and Western medicine Tat Cardiology, Binhai 224500,China; 2Binhai County, Jiangsu Province, Department of Cardiology, Second Peoples Hospital, Binhai 224500,China) 【 】 Antithrombotic treatment of atrial fibrillation and anticoagulant therapy in patients with the efficacy and ABSTRACT Objective: safety. Method: Retrospective analysis of 140 cases of hospitalized patients, 85 patients were randomly divided into the aspirin group and 55 cases of warfarin; observation of the efficacy and safety of the two groups. Results: Aspirin group, the incidence of ischemic events was significantly higher than the warfarin group (P 0.05); but warfarin bleeding event rate was significantly higher than the aspirin group (P0.05). Conclusion: For patients with atrial fibrillation should not only